Thymidylate synthase (via 5-FU, released from tegafur) and dihydropyrimidine dehydrogenase (inhibited by gimeracil)

Assets acting on this target.

Class
Oral fluoropyrimidine combination — tegafur (5-FU prodrug) + gimeracil (DPD inhibitor) + oteracil (OPRT inhibitor, gut-toxicity mitigant)
Pathway
Antimetabolite inhibition of DNA/RNA synthesis
Notes
original target text: Thymidylate synthase (via 5-FU, released from tegafur) and

Related mechanisms

← all mechanisms